ALLERGAN SALES, LLC et al v. TORRENT PHARMACEUTICALS LIMITED et al
| ALLERGAN USA, INC., ALLERGAN SALES, LLC, PIERRE FABRE MEDICAMENT S.A.S. and FOREST LABORATORIES HOLDINGS LIMITED |
| TORRENT PHARMA INC. and TORRENT PHARMACEUTICALS LIMITED |
| 2:2019cv21709 |
| December 20, 2019 |
| US District Court for the District of New Jersey |
| Steven C Mannion |
| Esther Salas |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 7, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Answer Due Deadline Update - The #12 Letter Request has been GRANTED. The answer due date has been set for 2/18/20. (jc, ) |
Filing 13
ORDER granting #12 Defendant Torrent Pharmaceuticals' Letter Request for an extension of time to February 18, 2020 to answer, move, or otherwise respond to #1 Plaintiffs' Complaint. Rule 16 Conference set for March 24, 2020 at 10:00 AM before Magistrate Judge Steven C. Mannion. Signed by Magistrate Judge Steven C. Mannion on 2/3/20. (jc, )
|
| Filing 12 Letter from Arnold B. Calmann, Esq. to the Honorable Steven C. Mannion, U.S.M.J. Requesting Extension of Time for Torrent to Answer, Move, or Otherwise Respond to Complaint re #1 Complaint,. (CALMANN, ARNOLD) |
| Filing 11 Application and Proposed Order for Clerk's Order to extend time to answer as to Plaintiffs' Complaint.. (CALMANN, ARNOLD) |
| Filing 10 NOTICE of Appearance by KATHERINE ANN ESCANLAR on behalf of TORRENT PHARMA INC., TORRENT PHARMACEUTICALS LIMITED (ESCANLAR, KATHERINE) |
| Filing 9 NOTICE of Appearance by ARNOLD B. CALMANN on behalf of TORRENT PHARMA INC., TORRENT PHARMACEUTICALS LIMITED (CALMANN, ARNOLD) |
| Clerk`s Text Order - The document #11 Application for Clerk's Order to Ext Answer/Proposed Order submitted by TORRENT PHARMA INC., TORRENT PHARMACEUTICALS LIMITED has been GRANTED. The answer due date has been set for 2/4/20. (jc, ) |
| Filing 8 NOTICE of Appearance by ZAHIRE DESIREE ESTRELLA-CHAMBERS on behalf of ALLERGAN SALES, LLC, ALLERGAN USA, INC., FOREST LABORATORIES HOLDINGS LIMITED, PIERRE FABRE MEDICAMENT S.A.S. (ESTRELLA-CHAMBERS, ZAHIRE) |
| Filing 7 NOTICE of Appearance by HECTOR DANIEL RUIZ on behalf of ALLERGAN SALES, LLC, ALLERGAN USA, INC., FOREST LABORATORIES HOLDINGS LIMITED, PIERRE FABRE MEDICAMENT S.A.S. (RUIZ, HECTOR) |
| Filing 6 AO120 Patent/Trademark Form filed. (Attachments: #1 Complaint and Attachments) (jc, ) |
| Filing 5 AO120 Patent/Trademark Form filed. (jc, ) |
| Filing 4 SUMMONS ISSUED as to TORRENT PHARMA INC., TORRENT PHARMACEUTICALS LIMITED. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jc, ) |
| Filing 3 Corporate Disclosure Statement by PIERRE FABRE MEDICAMENT S.A.S.. (WALSH, LIZA) |
| Filing 2 Corporate Disclosure Statement by ALLERGAN SALES, LLC, ALLERGAN USA, INC., FOREST LABORATORIES HOLDINGS LIMITED. (WALSH, LIZA) |
| Filing 1 COMPLAINT against TORRENT PHARMA INC., TORRENT PHARMACEUTICALS LIMITED ( Filing and Admin fee $ 400 receipt number 0312-10196820), filed by PIERRE FABRE MEDICAMENT S.A.S., ALLERGAN SALES, LLC, ALLERGAN USA, INC., FOREST LABORATORIES HOLDINGS LIMITED. (Attachments: #1 Exhibit A-E, #2 Civil Cover Sheet, #3 AO 120 Form)(WALSH, LIZA) |
| Case assigned to Judge Esther Salas and Magistrate Judge Steven C. Mannion. (jr) |
| CLERK'S QUALITY CONTROL MESSAGE - Please disregard #5 AO120 Patent/Trademark Form filed by the Clerk's office on 12/20/19. The patent cover sheet was not included. (jc, ) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
